Biostate AI specializes in multiomics data collection, offering advanced services in total RNA sequencing (RNASeq) at competitive prices. Their technology enables the analysis of various RNA types, including mRNA, IncRNA, miRNA, and piRNA, from diverse sample sources such as blood and FFPE tissue. The company emphasizes affordability and accessibility, with total RNASeq services starting at $80 per sample, allowing researchers to gain insights into gene expression and biological variations with minimal effort and cost. This approach supports studies on longitudinal changes, multi-organ impacts, and individual differences, making it a valuable resource for scientists.

In addition to their RNA sequencing services, Biostate AI provides accurate AI-generated figures and reports, enhancing the interpretability of the data collected. Their platform is designed to streamline the entire process from sample collection to insightful analysis, ensuring that researchers can focus on their scientific inquiries rather than the complexities of data handling. The company also offers grants for new investigators, allowing them to access RNA sequencing services at no cost, thereby fostering innovation and research in the scientific community.

United States

Biostate.AI is a startup founded in 2023 with the mission of developing generative AI for predictive omics analytics in the healthcare sector. They offer services such as RNA sequencing, DNA sequencing, image sequencing, image data analysis, and more. The company aims to lower costs and increase the utility of RNA sequencing for research and drug discovery.

Biostate AI

Company Details